LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Prothena Corp PLC

Avatud

SektorTervishoid

5.31 4.32

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

5

Max

5.38

Põhinäitajad

By Trading Economics

Sissetulek

-2.2M

-60M

Müük

705K

2.8M

Aktsiakasum

-1.12

Kasumimarginaal

-2,128.536

Töötajad

163

EBITDA

-682K

-65M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+397.75% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. aug 2025

Turustatistika

By TradingEconomics

Turukapital

-495M

251M

Eelmine avamishind

0.99

Eelmine sulgemishind

5.31

Uudiste sentiment

By Acuity

50%

50%

167 / 380 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Prothena Corp PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. juuni 2025, 20:45 UTC

Tulu

Broadcom 2Q Sales Climb on Booming AI Demand

5. juuni 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5. juuni 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5. juuni 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5. juuni 2025, 21:32 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. juuni 2025, 20:45 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:24 UTC

Tulu

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Rev $15B >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Net $4.97B >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q Adj EPS $1.58 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom 2Q EPS $1.03 >AVGO

5. juuni 2025, 20:15 UTC

Tulu

Broadcom Sees 3Q Rev $15.8B >AVGO

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5. juuni 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5. juuni 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5. juuni 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5. juuni 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5. juuni 2025, 18:26 UTC

Tulu

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5. juuni 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5. juuni 2025, 16:30 UTC

Omandamised, ülevõtmised, äriostud

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5. juuni 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. juuni 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5. juuni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5. juuni 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5. juuni 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5. juuni 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5. juuni 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Prothena Corp PLC Prognoos

Hinnasiht

By TipRanks

397.75% tõus

12 kuu keskmine prognoos

Keskmine 24.29 USD  397.75%

Kõrge 81 USD

Madal 4 USD

Põhineb 9 Wall Streeti analüütiku instrumendi Prothena Corp PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

9 ratings

4

Osta

4

Hoia

1

Müü

Tehniline skoor

By Trading Central

N/A / 7.35Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Very Strong Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

167 / 380 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Prothena Corp PLC

Prothena Corporation PLC is a late-stage clinical company. The Company is engaged in the protein dysregulation and a pipeline of therapeutics for devastating neurodegenerative and rare peripheral amyloid diseases. It is advancing a pipeline of therapeutic candidates around neurological dysfunction and the biology of misfolded proteins. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Birtamimab for the treatment of amyloid light-chain (AL) amyloidosis; prasinezumab for the treatment of Parkinson’s disease and other related synucleinopathies; and PRX004, for the treatment of Transthyretin amyloidosis (ATTR). The Company's pipeline also includes late-preclinical-stage programs targeting proteins implicated in neurological diseases including tau and amyloid beta (Aß) for the treatment of Alzheimer’s disease and other neurodegenerative disorders, and TDP-43 for the treatment of amyotrophic lateral sclerosis.